Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Phase II Trial of PD-1 Inhibitors With or Without Radiation in Patients With Advanced Melanoma

NCT05498805 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05498805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05498805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Phase II Trial of PD-1 Inhibitors With or Without Radiation in Patients With Advanced Melanoma
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Unknown status
Start date
August 15, 2022
Completion date
August 15, 2025
Enrollment
92 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the efficacy and safety of pd-1 inhibitors with or without radiotherapy in patients with advanced melanoma